NCT05996185 2026-04-14
Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
Yale University
Phase 2 Recruiting
Yale University
Universität des Saarlandes
European Organisation for Research and Treatment of Cancer - EORTC